CRYSTAL BIOSCIENCE, INC.
Humanized monoclonal antibodies targeting CCR5 epitopes for HIV treatment
- Sector
- Biotech
- Total capital
- $217K
- Federal grants
- $217K
- 1 award · 2016
- Rank in peer group#349 of 392
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 25
- 15 pending · first 2016
- Rank in peer group#6 of 392
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Novel avian CCR5 specific antibodies to block HIV transmission$217K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#6 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 25 granted of 40- PendingProduction Of Antibodies By Modification Of An Autonomous Heavy Chain Variable Domain By Gene ConversionUSPTOApplication 19559776
- GrantedProduction Of Antibodies By Modification Of An Autonomous Heavy Chain Variable Domain By Gene ConversionUSPTOUS 12,588,664
- GrantedHuman Glucose-dependent Insulinotropic Polypeptide Receptor (gipr) Antibodies And Methods Of Use Thereof To Inhibit Gip Receptor And SignalingUSPTOUS 12,583,930
Show all 40 patent records
- Production Of Antibodies By Modification Of An Autonomous Heavy Chain Variable Domain By Gene ConversionSep 3, 2026 · Application 19559776Pending
- Production Of Antibodies By Modification Of An Autonomous Heavy Chain Variable Domain By Gene ConversionMar 31, 2026 · US 12,588,664Granted
- Human Glucose-dependent Insulinotropic Polypeptide Receptor (gipr) Antibodies And Methods Of Use Thereof To Inhibit Gip Receptor And SignalingMar 24, 2026 · US 12,583,930Granted
- Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain IMar 19, 2026 · Application 19300610Pending
- Transgenic Chicken Having An Endogenous Immunoglobulin Heavy Chain Gene In Which The Igy CH1 Coding Sequence Is Functionally DeletedMar 10, 2026 · US 12,568,940Granted
- Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain IIFeb 10, 2026 · US 12,543,710Granted
- ANTI-CD38 Antibody And Methods Of Use ThereofJan 27, 2026 · US 12,534,537Granted
- Anti-B7-H3 Antibody and Methods of Use ThereofJan 8, 2026 · Application 19330763Pending
- Transgenic Chicken That Makes Antibodies With Long CDR-H3S Stabilized By Multiple Disulfide Bridges And Diversified By Gene ConversionDec 25, 2025 · Application 19309500Pending
- ANTI-B7-H3 Antibody And Methods Of Use ThereofOct 14, 2025 · US 12,441,802Granted
- Transgenic Chicken That Makes Antibodies With Long CDR-H3S Stabilized By Multiple Disulfide Bridges And Diversified By Gene ConversionSep 30, 2025 · US 12,428,471Granted
- Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain ISep 9, 2025 · US 12,408,640Granted
- Camelization Of A Human Variable Domain By Gene ConversionOct 1, 2024 · US 12,102,070Granted
- Anti-tigit Antibody And Methods Of Use ThereofAug 24, 2023 · Application 18015319Pending
- IN VIVO Method for Generating Diversity in a Protein ScaffoldJul 20, 2023 · Application 18107000Pending
- Anti-bdnf Antibodies And Methods Of Use ThereofJun 8, 2023 · Application 17922338Pending
- In Vivo Method for Generating Diversity in a Protein ScaffoldMar 14, 2023 · US 11,602,136Granted
- Transgenic Chicken Comprising an Inactivated Immunoglobulin GeneJan 3, 2023 · US 11,542,319Granted
- Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain IMay 24, 2022 · US 11,337,409Granted
- Transgenic Chicken For Production Of Antibodies Having A Common Light ChainJun 15, 2021 · US 11,033,009Granted
- Transgenic Chicken That Produces Human AntibodiesJan 7, 2021 · Application 16977430Pending
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsJun 23, 2020 · US 10,687,519Granted
- Transgenic Chicken Comprising an Inactivated Immunoglobulin GeneJun 23, 2020 · US 10,689,433Granted
- In Vivo Method for Generating Diversity in a Protein ScaffoldFeb 11, 2020 · US 10,555,508Granted
- Autologous Cells For Immunization Of ChickensAug 1, 2019 · Application 16332332Pending
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsJul 30, 2019 · US 10,362,770Granted
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsJan 8, 2019 · US 10,172,334Granted
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsJul 3, 2018 · US 10,010,058Granted
- In Vivo Method for Generating Diversity in a Protein ScaffoldMay 29, 2018 · US 9,982,062Granted
- Transgenic Chicken Comprising an Inactivated Immunoglobulin GeneNov 7, 2017 · US 9,809,642Granted
- Method For Culturing Avian GonocytesMay 9, 2017 · US 9,644,178Granted
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsJan 24, 2017 · US 9,549,538Granted
- Transgenic Animal For Production Of Antibodies Having Minimal CdrsAug 2, 2016 · US 9,404,125Granted
- In Vivo Method For Generating Diversity In A Protein ScaffoldJul 19, 2016 · US 9,394,372Granted
- Polypeptides That Bind To NKP46Application 63785572Pending
- ANTI-B7-H3 Antibody And Methods Of Use ThereofApplication 62870549Pending
- ANTI-CD38 Antibody And Methods Of Use ThereofApplication 62870542Pending
- Transgenic Animal For Producing Diversified Antibodies That Have The Same Light Chain IIApplication PCTUS2019035529Pending
- Camelization Of A Human Variable Domain By Gene ConversionApplication PCTUS2019035525Pending
- Production Of Antibodies By Modification Of An Autonomous Heavy Chain Variable Domain By Gene ConversionApplication PCTUS2019035521Pending
Related companies, and why
- CELLULAR VEHICLES INC.Similar federal contract value in Biotech · null in contracts
- GRUTHAN BIOSCIENCE LLCSimilar federal contract value in Biotech · null in contracts
- ALZARROK BIO LLCSimilar federal contract value in Biotech · null in contracts
- Novelmed Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- SAB Biotherapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Atsena Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .